Haas Kevin Richard
SEC CIK 1843872 · EDGAR
Most active insiders at VCYT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stapley Marc | CEO, Dir | — | $8.92M |
| 2 | JONES EVAN/ FA | Dir | — | $2.00M |
| 3 | Chambers Rebecca | CFO | — | $1.91M |
| 4 | McGuire Annie | SVP, GC | — | $1.80M |
| 5 | Wygant Jonathan | VP, CAO | — | $1.54M |
| 6 | EASTHAM KARIN | Dir | — | $1.49M |
| 7 | Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| 8 | Leite John | Gbl Chief Commercial Off | — | $1.34M |
| 9 | EPSTEIN ROBERT S | Dir | — | $1.19M |
| 10 | Holstein Jens | Dir | — | $628.3K |
| 14 | Haas Kevin Richard | Chief Dev, Tech Off | — | — |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-14 17:03 | 2026-04-10 | VCYT | VERACYTE, INC. | Haas Kevin Richard | Chief Dev, Tech Off | A - Grant | $0.00 | +44.2K | 44.2K | New | $0 | |
| M | 2026-03-16 | 2026-03-13+ | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $4.66 | -22.3K | 191.8K | -10% | -$104.0K |
| 2026-02-03 | 2026-02-02 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | A - Grant | $0.00 | +23.7K | 202.3K | +13% | $0 | |
| M | 2025-03-25 | 2025-03-22+ | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $10.00 | -9,088 | 178.6K | -5% | -$90.9K |
| M | 2025-03-17 | 2025-03-14+ | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $10.07 | -7,725 | 191.1K | -4% | -$77.8K |
| 2025-03-17 | 2025-03-13 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | A - Grant | $0.00 | +54.1K | 195.4K | +38% | $0 | |
| 2025-03-04 | 2025-02-07 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | A - Grant | $0.00 | +12.8K | 141.3K | +10% | $0 | |
| 2025-02-26 | 2025-02-25 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $11.74 | -1,016 | 128.6K | -0.8% | -$11.9K | |
| 2024-10-10 | 2024-10-09 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $24.37 | -2,515 | 129.6K | -2% | -$61.3K | |
| M | 2024-03-25 | 2024-03-22+ | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $22.24 | -4,575 | 132.1K | -3% | -$101.7K |
| 2024-03-18 | 2024-03-15 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $21.16 | -3,306 | 136.7K | -2% | -$70.0K | |
| 2024-03-18 | 2024-03-14 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | A - Grant | $0.00 | +35.2K | 140.0K | +34% | $0 | |
| 2024-02-26 | 2024-02-25 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $22.72 | -881 | 104.8K | -0.8% | -$20.0K | |
| 2023-10-10 | 2023-10-09 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $15.01 | -1,710 | 105.7K | -2% | -$25.7K | |
| 2023-09-27 | 2023-09-26 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $15.99 | -858 | 107.4K | -0.8% | -$13.7K | |
| M | 2023-03-27 | 2023-03-24 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $23.72 | -2,816 | 108.2K | -3% | -$66.8K |
| 2023-03-23 | 2023-03-22 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $22.91 | -1,677 | 111.1K | -1% | -$38.4K | |
| 2023-03-16 | 2023-03-15 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | A - Grant | $0.00 | +28.5K | 112.7K | +34% | $0 | |
| 2023-02-27 | 2023-02-25 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $18.54 | -1,012 | 84.3K | -1% | -$18.8K | |
| 2022-10-11 | 2022-10-09 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $19.62 | -1,721 | 85.3K | -2% | -$33.8K | |
| M | 2022-09-27 | 2022-09-25+ | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $18.49 | -1,208 | 87.9K | -1% | -$22.3K |
| M | 2022-03-25 | 2022-03-24 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $25.32 | -2,842 | 89.9K | -3% | -$72.0K |
| 2022-03-23 | 2022-03-22 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | A - Grant | $0.00 | +19.2K | 91.1K | +27% | $0 | |
| 2022-02-28 | 2022-02-25 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $24.69 | -865 | 71.8K | -1% | -$21.4K | |
| 2022-02-18 | 2022-02-16 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | A - Grant | $0.00 | +19.5K | 72.7K | +37% | $0 | |
| 2021-10-12 | 2021-10-09 | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $30.88 | -1,729 | 53.2K | -3% | -$53.4K | |
| M | 2021-09-27 | 2021-09-25+ | MYGN | MYRIAD GENETICS INC | Haas Kevin Richard | CTO | F - Tax | $33.31 | -1,211 | 55.8K | -2% | -$40.3K |
Purchase Sale Sale after option exercise All abbreviations